Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors
Results from two studies indicate the nonselective serotonin reuptake inhibitor (SRI) clomipramine is more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in children with autism. A study of the selective SRI fluvoxamine found it to be significantl...
Saved in:
Published in | Journal of autism and developmental disorders Vol. 30; no. 5; pp. 427 - 438 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Springer Nature B.V
01.10.2000
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Results from two studies indicate the nonselective serotonin reuptake inhibitor (SRI) clomipramine is more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in children with autism. A study of the selective SRI fluvoxamine found it to be significantly better than placebo for reducing repetitive phenomena and aggression. (Contains references.) (Author/CR) |
---|---|
Bibliography: | Special Issue: Treatments for People with Autism and Other Pervasive Developmental Disorders: Research Perspectives. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0162-3257 1573-3432 |
DOI: | 10.1023/a:1005551523657 |